Sun Pharma shares in action on acquisition update of US-based Organon & Co for $11.75 billion
Mumbai: Shares of Sun Pharmaceutical Industries surged over 9ย per cent on Monday, April 27, 2026, after the firm announced that it will acquire US-based Organon & Co in an all-cash deal at an enterprise valuation of USD 11.75 billion. The stock reacted positively to this development, as it is expected to be one of the largest acquisitions by Indian firms overseas.ย Following this update, the stock opened in the green at Rs 1,632.50, up Rs 12.55 from the previous close of Rs 1,619.95 on the BSE. Amid a spurt in volume by more than 4.69 times, the stock advanced to touch…